Bundamedik Tbk vs Citra Buana Prasida Tbk. — how do they compare? Bundamedik Tbk trades at Rp188 (market cap 1.63T, 725.9K 24h volume), while Citra Buana Prasida Tbk. trades at Rp535 (market cap 725.59B, 295.9K 24h volume). The key difference: Bundamedik Tbk is far larger — about 2.2× Citra Buana Prasida Tbk.'s market cap, and Bundamedik Tbk is more actively traded (725.9K versus 295.9K). Which is the better fit depends on your goals.
| BMHS | CBPE | |
|---|---|---|
Market Cap | 1.63T | 725.59B |
Volume | 725.9K | 295.9K |
Lot | 7.26K | 2.96K |
Turnover | 135.94M | 165.79M |
Average Price | 187.26 | 560.28 |
Value | 135.94M | 165.79M |
Indicative Equilibrium Price | 188 | 580 |
Indicative Equilibrium Volume | 1 | 526 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →PT Citra Buana Prasida Tbk Entity which was originally named PT Prasetia Sejati was established on August 24, 2000 based on the Deed of Establishment No. 18, drawn up in the presence of Ninik Sukadarwati, SH., Notary of the Bekasi Regency Level II, in Tambun. The Entity started its commercial business in 2005.
Read more on CBPE →